Benefit Plans (Tables)

6 Months Ended

Dec. 31, 2016

Benefit Plans

Summary of shares available for grant under our equity incentive plans

	Number of Shares
Available for grant at July 1, 2016	6,244
RSUs granted	(746)
Shares withheld in settlement of taxes and/or exercise price	179
Forfeitures	37
Shares removed	(38)
Available for grant at December 31, 2016	5,676

Schedule of stock-based compensation expense related to stock options, restricted stock units and the Employee Stock Purchase Plan

	Three months ended December 31,				Six months ended December 31,
	2015		2016		2015		2016
Cost of revenue – recurring	$	448	$	593	$	805	$	1,136
Cost of revenue – non-recurring		304		367		574		668
Sales and marketing		1,205		1,683		2,118		3,208
Research and development		815		870		1,384		1,664
General and administrative		2,008		3,122		3,611		5,772
Total stock-based compensation expense	$	4,780	$	6,635	$	8,492	$	12,448

Summary of the assumptions used for estimating the fair value of stock options granted

	Period ended
	December 31,
	2015
Valuation assumptions:
Expected dividend yield	0	%
Expected volatility	34.0	%
Expected term (years)	6.25
Risk-free interest rate	1.83	%

Schedule of stock option activity

	Outstanding Options
				Weighted
		Weighted		average
		average		remaining	Aggregate
	Number of	exercise		contractual	intrinsic
	shares	price		term (years)	value
Balance at July 1, 2016	3,464	$	11.75	6.70	$	108,944
Options forfeited	(11)		17.00
Options exercised	(191)		13.81
Balance at December 31, 2016	3,262	$	11.61	6.17	$	60,783
Options exercisable at December 31, 2016	2,354	$	8.57	5.70	$	50,648
Options vested and expected to vest at December 31, 2016	3,235	$	11.50	6.16	$	60,578

Schedule of restricted stock unit activity

	Units	Weighted average grant date fair value
RSU balance at July 1, 2016	1,003	$	32.74
RSUs granted	746	$	45.45
RSUs vested	(222)	$	31.86
RSUs forfeited	(26)	$	38.48
RSU balance at December 31, 2016	1,501	$	39.06
RSUs expected to vest at December 31, 2016	1,318	$	38.88

Summary of weighted average assumptions used for estimating grant date fair value of ESPP

	Period ended
	December 31,
	2015		2016
Valuation assumptions:
Expected dividend yield	0	%	0	%
Expected volatility	44.1 - 48.4	%	38.9 - 53.4	%
Expected term (years)	0.5		0.5
Risk‑free interest rate	0.11 - 0.31	%	0.28 - 0.61	%